THERAPEUTICALLY USEFUL COMPOUND,LEUPEPTINS,AND PROCESSES FOR THE PREPARATION THEREOF

1,268,212. Enzyme-inhibitor compositions. ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI. 10 April, 1969 [19 April, 1968, 25 March, 1969], No. 18421/69. Heading A5B. '[Also in Division C2] Pharmaceutical compositions which inhibit the enzymatic reactions of trypsin, papain, kallikrein, plasmin and t...

Full description

Saved in:
Bibliographic Details
Main Authors UMEZAWA H,JA, TAKEUCHI T,JA, MAEDA K,JA, HAMADA M,JA, AOYAGI T,JA, HARA T,JA
Format Patent
LanguageEnglish
Published 08.10.1974
Edition2
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1,268,212. Enzyme-inhibitor compositions. ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI. 10 April, 1969 [19 April, 1968, 25 March, 1969], No. 18421/69. Heading A5B. '[Also in Division C2] Pharmaceutical compositions which inhibit the enzymatic reactions of trypsin, papain, kallikrein, plasmin and thrombokinase, which inhibit fibrinolysis, kinin formation from kininogen and blood coagulation and which are useful as anti-inflammatory agents comprise a compound I R 3 CONH-CH(R 2 )-CONH-CH(R 1 )- CONH-CH(CHO)-(CH 2 ) 3 -NHC=(NH)NH 2 wherein R 1 and R 2 are CH(CH 3 ) 2 , CH 2 CH (CH 3 ) 2 or -CH(CH 3 )CH 2 CH 3 and R 3 is CH 3 of C 2 H 5 , and optionally antihistamines, sulpha drugs, liptropic agents, CNS stimulants, local anaesthetics, analgesics, laxatixes, sedatives, antibiotics, vitamins, hormones, anabolic agents and/or antifungal agents. Specific examples of which are mentioned. The compositions may be administered orally, parenterally or topically.
Bibliography:Application Number: US19720263172